title: [Tadenan treatment of prostatic adenoma].
abstract: Tadenan, a drug of plant origin, was given to 27 patients with documented prostatic adenoma for 3-12 months. Home uroflowmonitoring for 1, 3, 6 and 12 months registered positive changes in urinary flow rate and urination volume. Side effects were absent. IPSS and QoL parameters were also assessed.
authors.forename: V V
authors.initials: VV
authors.lastname: Danilov
authors.forename: E V
authors.initials: EV
authors.lastname: Elisseva
authors.forename: A V
authors.initials: AV
authors.lastname: Vasil'chenko
mesh_terms: D000368:Aged; D005233:Fatty Alcohols / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008875:Middle Aged; D010936:Plant Extracts / Q000008:administration & dosage*; D011470:Prostatic Hyperplasia / Q000188:drug therapy* / Q000503:physiopathology; D011788:Quality of Life; D014554:Urination / Q000187:drug effects
chemical_list: D005233:Fatty Alcohols; D010936:Plant Extracts; C009375:Tadenan